KRUTOVA, Marcela, Vaclav CAPEK, Elka NYCOVA, Sabina VOJACKOVA, Magda BALEJOVA, Lenka GEIGEROVA, Renata TEJKALOVÁ, Lenka HAVLINOVA, Iva VAGNEROVA, Pavel CERMAK, Lenka RYSKOVA, Petr JEZEK, Dana ZAMAZALOVA, Denisa VESELA, Alice KUCHAROVA, Dana NEMCOVA, Martina CURDOVA, Otakar NYC a Pavel DREVINEK. The association of a reduced susceptibility to moxifloxacin in causativeClostridium(Clostridioides)difficilestrain with the clinical outcome of patients. ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL. LONDON: BMC, 2020, roč. 9, č. 1, s. 1-7. ISSN 2047-2994. Dostupné z: https://dx.doi.org/10.1186/s13756-020-00765-y.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název The association of a reduced susceptibility to moxifloxacin in causativeClostridium(Clostridioides)difficilestrain with the clinical outcome of patients
Autoři KRUTOVA, Marcela (203 Česká republika), Vaclav CAPEK (203 Česká republika), Elka NYCOVA (203 Česká republika), Sabina VOJACKOVA (203 Česká republika), Magda BALEJOVA (203 Česká republika), Lenka GEIGEROVA (203 Česká republika), Renata TEJKALOVÁ (203 Česká republika, domácí), Lenka HAVLINOVA (203 Česká republika), Iva VAGNEROVA (203 Česká republika), Pavel CERMAK (203 Česká republika), Lenka RYSKOVA (203 Česká republika), Petr JEZEK (203 Česká republika), Dana ZAMAZALOVA (203 Česká republika), Denisa VESELA (203 Česká republika), Alice KUCHAROVA (203 Česká republika), Dana NEMCOVA (203 Česká republika), Martina CURDOVA (203 Česká republika), Otakar NYC (203 Česká republika) a Pavel DREVINEK (203 Česká republika).
Vydání ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, LONDON, BMC, 2020, 2047-2994.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10606 Microbiology
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.887
Kód RIV RIV/00216224:14110/20:00116176
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1186/s13756-020-00765-y
UT WoS 000552013900002
Klíčová slova anglicky Clostridium difficileinfection; Clostridioides difficileinfection; Czech Republic; PCR ribotype 001; PCR ribotype 176; Moxifloxacin; Mortality
Štítky 14110113, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 10. 8. 2020 13:07.
Anotace
Objectives To investigate the relationship betweenClostridium (Clostridioides) difficilestrain characteristics andC. difficileinfection (CDI) outcome. Methods Between October and December 2017, 16 hospitals collected epidemiological data according to the European Centre for Disease Prevention and Control (ECDC) surveillance protocol for CDI.C. difficileisolates were characterized by ribotyping, toxin genes detection and antibiotic susceptibility testing to metronidazole, vancomycin and moxifloxacin. Results The overall mean CDI incidence density was 4.5 [95% CI 3.6-5.3] cases per 10,000 patient-days. From the 433 CDI cases, 330 (76.2%) were healthcare-associated, 52 (12.0%) cases were community-associated or of unknown origin and 51 (11.8%) CDI cases recurrent; a complicated course of CDI was reported in 65 cases (15.0%). Eighty-eight (20.3%) of patients died and 59 of them within 30 days after the CDI diagnosis. From the 379C. difficileisolates, the most prevalent PCR ribotypes were 001 (n = 127, 33.5%) and 176 (n = 44, 11.6%). A total of 186 (49.1%) isolates showed a reduced susceptibility to moxifloxacin (> 4 mg/L) and 96.4% of them had Thr82Ile in the GyrA. Nineteen isolates revealed reduced susceptibility to metronidazole and two isolates to vancomycin (> 2 mg/L). A fatal outcome was associated with a reduced susceptibility to moxifloxacin, the advanced age of the patients and a complicated course of CDI (p<0.05). No association between ribotype, binary toxin and a reduced susceptibility to moxifloxacin and complicated course or recurrent CDI was found. Conclusions A reduced susceptibility to moxifloxacin, in causativeC. difficilestrains was associated with fatal outcome of the patients, therefore it is an important marker in surveillance of CDI.
VytisknoutZobrazeno: 24. 8. 2024 01:24